PatientsVille.com Logo

PatientsVille

Ascal Side Effects

Common Ascal Side Effects


The most commonly reported Ascal side effects (click to view or check a box to report):

Cerebrovascular Accident (3)
Fatigue (3)
Dyspnoea (3)
Embolism (2)
Depressed Mood (2)
Cardiac Failure Congestive (2)
Conjunctivitis (2)
Cough (2)
Fluid Retention (2)
Myalgia (2)
Gout (2)
Multi-organ Failure (2)
Skin Disorder (2)
Metastases To Lung (2)
Hyperhidrosis (2)
Pleural Effusion (1)
Pneumonia (1)
Parathyroid Tumour (1)
Pancytopenia (1)
Pleural Calcification (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Ascal Side Effects Reported to FDA

The following Ascal reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Ascal on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Embolism, Arm Amputation
This is a report of a 69-year-old male patient (weight: NA) from NETHERLANDS, suffering from the following symptoms/conditions: NA, who was treated with Ascal /00002702/ (dosage: Unk, start time: Jan 01, 2009), combined with:
  • Enbrel (50 Mg, Weekly)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Embolism
  • Arm Amputation
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ascal /00002702/ treatment in male patients, resulting in embolism side effect. The patient was hospitalized and became disabled.

Eye Infection, Strabismus, Eye Discharge
This report suggests a potential Ascal Eye Infection, Strabismus, Eye Discharge side effect(s) that can have serious consequences. A 86-year-old female patient (weight: NA) from NETHERLANDS was diagnosed with the following symptoms/conditions: NA and used Ascal (dosage: NA) starting Jan 06, 2012. Soon after starting Ascal the patient began experiencing various side effects, including:
  • Eye Infection
  • Strabismus
  • Eye Discharge
Drugs used concurrently:
  • Proton Pump Inhibitors
  • Simvastatin
  • Imatinib Mesylate (400 Mg, Once Daily)
  • Betahistine
Although Ascal demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as eye infection, may still occur.

Off Label Use, Blood Calcium Increased, Therapeutic Response Unexpected, Parathyroid Tumour
This Off Label Use, Blood Calcium Increased, Therapeutic Response Unexpected, Parathyroid Tumour problem was reported by a consumer or non-health professional from UNITED STATES. A 91-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Ascal (dosage: 1 Df, Qd). The following drugs were being taken at the same time: NA. When commencing Ascal, the patient experienced the following unwanted symptoms/side effects:
  • Off Label Use
  • Blood Calcium Increased
  • Therapeutic Response Unexpected
  • Parathyroid Tumour
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as off label use, may become evident only after a product is in use by the general population.

Anaemia, Hyperglycaemia, Diarrhoea
This is a report of a female patient (weight: NA) from NETHERLANDS. The patient developed the following symptoms/conditions: atherosclerosis prophylaxis,type 2 diabetes mellitus,hypertension,macular oedema and was treated with Ascal (dosage: NA) starting Nov 04, 2011. Concurrently used drugs:
  • Metformin Hcl (1500 Mg)
  • Perindopril Erbumine
  • Ranibizumab
  • Metformin Hcl (1000 Mg)
  • Strumazol
  • Atorvastatin Calcium
  • Nexium (20 Mg)
  • Chloorampenicol
Soon after that, the consumer experienced the following side effects:
  • Anaemia
  • Hyperglycaemia
  • Diarrhoea
The patient was hospitalized. This opens a possibility that Ascal treatment could cause the above reactions, including anaemia, and some female subjects may be more susceptible.


Deep Vein Thrombosis
A 62-year-old female patient (weight: NA) from NETHERLANDS with the following symptoms/conditions: thrombosis,diabetes mellitus,depression,diffuse large b-cell lymphoma started Ascal treatment (dosage: 100 Mg, Qd) on Apr 19, 2010. Soon after starting Ascal treatment, the subject experienced various side effects, including:
  • Deep Vein Thrombosis
Concurrently used drugs:
  • Tolbutamide (500 Mg, Tid)
  • Clomipramine Hcl (25 Mg, Qd)
  • Doxorubicin Hcl (100 Mg, Unk)
  • Prednisone (100 Mg, Unk)
  • Metoprolol Tartrate (100 Mg, Qd)
  • Rituximab (750 Mg, Unk)
  • Pegfilgrastim (6 Mg, Unk)
  • Cyclosporine (1500 Mg, Unk)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Ascal.

Embolism
A 69-year-old male patient from NETHERLANDS (weight: NA) experienced symptoms, such as: NA and was treated with Ascal /00002702/(dosage: Unk). The treatment was initiated on Jan 01, 2009. After that a consumer reported the following side effect(s):
  • Embolism
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Ascal /00002702/ efficacy:
  • Enbrel (50 Mg, Weekly)
The patient was hospitalized and became disabled.

Tongue Oedema, Glossodynia, Cerebrovascular Accident
In this report, Ascal Cardio Effervescent was administered for the following condition: NA.A female consumer from NETHERLANDS (weight: NA) started Ascal Cardio Effervescent treatment (dosage: NA) on Dec 23, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Tongue Oedema
  • Glossodynia
  • Cerebrovascular Accident
A possible interaction with other drugs could have contributed to this reaction:
  • Temazepam Cf
  • Amlodipine
  • Simvastatin Pch
  • Hydrochlorothiazide
  • Rasilez (1 Df, Bid)
  • Persantin
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Ascal Cardio Effervescent treatment could be related to the listed above side effect(s).

Atrial Fibrillation, Circulatory Collapse
This is a report of the following Ascal side effect(s):
  • Atrial Fibrillation
  • Circulatory Collapse
A male patient from NETHERLANDS (weight: NA) presented with the following condition: NA and received a treatment with Ascal (dosage: 80 Milligram) starting: Mar 06, 2012.The following concurrently used drugs could have generated interactions:
  • Nexium (40 Milligram)
  • Thalidomide (200 Milligram)
  • Melphalan Hydrochloride (14 Milligram)
  • Amlodipine (5 Milligram)
  • Lipitor (40 Milligram)
  • Tolbutamide (500 Milligram)
  • Nitroglycerin (.8 Milligram)
  • Metformin Hcl (1000 Milligram)
The patient was hospitalized.This report suggests that a Ascal treatment could be associated with the listed above side effect(s).

Pleural Effusion, Metastases To Lung
This Ascal Cardio (carbasalate Calcium) report was submitted by a 66-year-old male consumer from NETHERLANDS (weight: NA). The patient was diagnosed with: NA and Ascal Cardio (carbasalate Calcium) was administered (dosage: NA) starting: Oct 20, 2011. The consumer developed a set of symptoms:
  • Pleural Effusion
  • Metastases To Lung
Other drugs used simultaneously:
  • Somatuline Depot
  • Tolbutamide
  • Metoprolol Succ (metoprolol Succinate)
  • Lisinopril
  • Panzytrat (pancreatin)
  • Somatuline Depot (120mg (120 Mg, 1 In 28 D), Intramuscular)
  • Somatuline Depot
The patient was hospitalized.Those unexpected symptoms could be linked to a Ascal Cardio (carbasalate Calcium) treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Pulmonary Oedema, Metastases To Lung
This is a report of a possible correlation between Ascal Cardio (carbasalate Calcium) use and the following symptoms/side effect(s):
  • Pulmonary Oedema
  • Metastases To Lung
which could contribute to an assessment of Ascal Cardio (carbasalate Calcium) risk profile.A 66-year-old male consumer from NETHERLANDS (weight: NA) was suffering from NA and was treated with Ascal Cardio (carbasalate Calcium) (dosage: NA) starting Oct 20, 2011.Other concurrent medications:
  • Somatuline Depot
  • Somatuline Depot
  • Tolbutamide
  • Somatuline Depot (120mg (120mg, 1 In 128 D), Intramuscular)
  • Panzytrat (pancreatin)
  • Metoprolol Succ (metoprolol Succinate)
  • Lisinopril
The patient was hospitalized.

Chills, Heart Rate Irregular, Agitation, Chest Pain, Insomnia, Fatigue, Angina Pectoris, Muscle Spasms
A female patient from NETHERLANDS (weight: NA) presented with the following symptoms: NA and after a treatment with Ascal Cardio (dosage: 1sac Per Day) experienced the following side effect(s):
  • Chills
  • Heart Rate Irregular
  • Agitation
  • Chest Pain
  • Insomnia
  • Fatigue
  • Angina Pectoris
  • Muscle Spasms
The treatment was started on Dec 07, 2011. Ascal Cardio was used in combination with the following drugs:
  • Propafenone Hcl (150mg Three Times Per Day)
  • Coveram (1tab Per Day)
The patient was hospitalized.This report could alert potential Ascal Cardio consumers.

Dyspnoea, Lung Infection
In this report, a male patient from NETHERLANDS (weight: NA) was affected by a possible Ascal side effect.The patient was diagnosed with NA. After a treatment with Ascal (dosage: NA, start date: Nov 09, 2011), the patient experienced the following side effect(s):
  • Dyspnoea
  • Lung Infection
The following simultaneously used drugs could have led to this reaction:
  • Procoralan (0.5 1dd)
  • Tolbutamide (50 Mg, 2dd1)
  • Tobi (28 Mg, Unk)
  • Metformin Hcl (500 Mg, 2dd2)
  • Spiriva (18 Mg, 1dd1)
  • Foster (100/6 2dd2)
  • Omeprazole (20 Mg, 1dd1)
  • Tamsulosin Hydrochloride
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Ascal treatment.

Cardiac Arrest, Streptococcal Bacteraemia, Granulocytopenia, Multi-organ Failure, Respiratory Failure
This is a report of a male patient from NETHERLANDS (weight: NA), who used Ascal (dosage: 100 Mg, Unk) for a treatment of cardiac disorder,acute myeloid leukaemia. After starting a treatment on Sep 22, 2010, the patient experienced the following side effect(s):
  • Cardiac Arrest
  • Streptococcal Bacteraemia
  • Granulocytopenia
  • Multi-organ Failure
  • Respiratory Failure
The following drugs could possibly have interacted with the Ascal treatment
  • Evoltra (27 Mg, Qdx5)
  • Cytarabine (1800 Mg, Qd)
  • Metoprolol Tartrate (100 Mg, Unk)
  • Simvastatin (20 Mg, Unk)
  • Amsacrine (215 Mg, Qdx3)
  • Metformin Hydrochloride (500 Mg, Unk)
Taken together, these observations suggest that a Ascal treatment could be related to side effect(s), such as Cardiac Arrest, Streptococcal Bacteraemia, Granulocytopenia, Multi-organ Failure, Respiratory Failure.

Lacunar Infarction
This lacunar infarction side effect was reported by a physician from NETHERLANDS. A 72-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Ascal (dosage: NA), which was started on NS. Concurrently used drugs:
  • Xeloda
  • Proscar
  • Persantin
  • Simvastatin
  • Oxaliplatin
  • Doxazosin Mesylate
  • Metformin Hcl
  • Metoprolol Tartrate
When starting to take Ascal the consumer reported the following symptoms:
  • Lacunar Infarction
The patient was hospitalized. These side effects may potentially be related to Ascal.

Myelodysplastic Syndrome, Pancytopenia
This is a Ascal /00002702/ side effect report of a 94-year-old male patient (weight:NA) from NETHERLANDS, suffering from the following symptoms/conditions: prophylaxis,cardiac failure,hypertension, who was treated with Ascal /00002702/ (dosage:100 Mg, Unk, start time: Jun 14, 2011), combined with:
  • Furosemide (20 Mg, Qd)
  • Amlodipine (10 Mg, Unk)
  • Omeprazole (40 Mg, Unk)
  • Aranesp (10 Mug, Qwk)
  • Novomix /01475801/ (Unk Unk, Q12h)
, and developed a serious reaction and a myelodysplastic syndrome side effect. The patient presented with:
  • Myelodysplastic Syndrome
  • Pancytopenia
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Ascal /00002702/ treatment in male patients suffering from prophylaxis,cardiac failure,hypertension, resulting in myelodysplastic syndrome.

Skin Disorder, Cerebrovascular Accident
This report suggests a potential Ascal /00002702/ skin disorder side effect(s) that can have serious consequences. A 44-year-old male patient from NETHERLANDS (weight:NA) was diagnosed with the following health condition(s): NA and used Ascal /00002702/ (dosage: Unk) starting NS. Soon after starting Ascal /00002702/ the patient began experiencing various side effects, including:
  • Skin Disorder
  • Cerebrovascular Accident
Drugs used concurrently:
  • Losec /00661201/ (Unk)
  • Enbrel (50 Mg, 2x/week)
  • Insulin Detemir (Unk)
  • Hydrochlorothiazide (Unk)
  • Mtx /00113801/ (Unk)
  • Folic Acid (Unk)
  • Persantin (Unk)
  • Enalapril Maleate (Unk)
Although Ascal /00002702/ demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as skin disorder, may still occur.

Subarachnoid Haemorrhage, Pyrexia
This subarachnoid haemorrhage problem was reported by a consumer or non-health professional from UNITED KINGDOM. A female patient (weight: NA) was diagnosed with the following medical condition(s): amaurosis fugax,diffuse large b-cell lymphoma.On Jun 03, 2011 a consumer started treatment with Ascal (dosage: Unk). The following drugs/medications were being taken at the same time:
  • Doxorubicin Hcl (85 Mg, Unk)
  • Persantin (Unk)
  • Prednisone Tab (100 Mg, Unk)
  • Neupogen (6 Mg, Unk)
  • Cyclophosphamide (1275 Mg, Unk)
  • Rituximab (640 Mg, Unk)
When commencing Ascal, the patient experienced the following unwanted symptoms /side effects:
  • Subarachnoid Haemorrhage
  • Pyrexia
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as subarachnoid haemorrhage, may become evident only after a product is in use by the general population.

Skin Disorder, Cerebrovascular Accident
This is a Ascal /00002702/ side effect report of a 44-year-old male patient (weight: NA) from NETHERLANDS. The patient developed the following symptoms/conditions: NA and was treated with Ascal /00002702/ (dosage: Unk) starting NS. Concurrently used drugs:
  • Persantin (Unk)
  • Mtx /00113801/ (Unk)
  • Levemir (Unk)
  • Hydrochlorothiazide (Unk)
  • Actrapid /00030501/ (Unk Unk, Unk)
  • Folic Acid (Unk)
  • Enalapril Maleate (Unk)
  • Losec /00661201/ (Unk)
Soon after that, the consumer experienced the following of symptoms:
  • Skin Disorder
  • Cerebrovascular Accident
This opens a possibility that Ascal /00002702/ could cause skin disorder and that some male patients may be more susceptible.

Intestinal Obstruction, Amniorrhoea, Fungal Infection, Pregnancy, Weight Decreased, Crohn's Disease, Premature Delivery
A female patient (weight: NA) from UNITED STATES with the following symptoms: crohn's disease,pain started Ascal treatment (dosage: NA) on Sep 26, 2009. Soon after starting Ascal treatment, the consumer experienced several side effects, including:
  • Intestinal Obstruction
  • Amniorrhoea
  • Fungal Infection
  • Pregnancy
  • Weight Decreased
  • Crohn's Disease
  • Premature Delivery
. Concurrently used drugs:
  • Hydromorphone Hcl (1/2 Tablet Every 3 Hours As Needed)
  • Protonix
  • Amoxicillin
  • Ciprofloxacin
  • Cimzia
  • Cimzia
  • Melphalan Hydrochloride
  • Saline Flush/heparin (Daily Dose 100 Units/ml)
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Ascal side effects, such as intestinal obstruction.

Gout
This gout side effect was reported by a consumer or non-health professional from GERMANY. A 61-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Ascal (dosage: Unk), which was started on Feb 04, 2011. Concurrently used drugs:
  • Simvastatin (10 Mg, Qd)
  • Pantoprazole (Unk)
  • Sorafenib (raf Kinase Inhibitor) (400 Mg, Bid)
.When starting to take Ascal the consumer reported symptoms, such as:
  • Gout
These side effects may potentially be related to Ascal. The patient was hospitalized.

Gout
This is a report of a 61-year-old female patient (weight: NA) from GERMANY, suffering from the following symptoms/conditions: NA, who was treated with Ascal (dosage: Unk, start time: Feb 04, 2011), combined with:
  • Pantozol (Unk)
  • Simvastatin (10 Mg, Qd)
  • Sorafenib (raf Kinase Inhibitor) (400 Mg, Bid)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Gout
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ascal treatment in female patients, resulting in gout side effect. The patient was hospitalized.

Vomiting, Abdominal Pain, Haematochezia
This report suggests a potential Ascal Vomiting, Abdominal Pain, Haematochezia side effect(s) that can have serious consequences. A 82-year-old female patient (weight: NA) from NETHERLANDS was diagnosed with the following symptoms/conditions: NA and used Ascal (dosage: NA) starting Jul 20, 2005. Soon after starting Ascal the patient began experiencing various side effects, including:
  • Vomiting
  • Abdominal Pain
  • Haematochezia
Drugs used concurrently:
  • Furosemide
  • Carvedilol
  • Haloperidol
  • Acetylcysteine (Powder In Sachet.)
  • Perindopril Erbumine
  • Atrovent
  • Protagens (Tube. 20 Mg/ml.)
  • Plavix
The patient was hospitalized. Although Ascal demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as vomiting, may still occur.

Psoriasis, Rheumatoid Arthritis
This Psoriasis, Rheumatoid Arthritis problem was reported by a consumer or non-health professional from NETHERLANDS. A 57-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Dec 16, 2010 this consumer started treatment with Ascal /00002702/ (dosage: Unk). The following drugs were being taken at the same time:
  • Silver Sulfadiazine (Unk)
  • Enbrel (50 Mg, Weekly)
  • Ice (Unk)
  • Flixonase /00972202/ (Unk)
  • Fluvastatin (Unk)
  • Enbrel
  • Azathioprine (Unk)
  • Nexium (Unk)
When commencing Ascal /00002702/, the patient experienced the following unwanted symptoms/side effects:
  • Psoriasis
  • Rheumatoid Arthritis
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as psoriasis, may become evident only after a product is in use by the general population.

Prinzmetal Angina
This is a report of a 69-year-old male patient (weight: NA) from NETHERLANDS. The patient developed the following symptoms/conditions: NA and was treated with Ascal (dosage: 100 Mg, Unk) starting Jan 01, 2009. Concurrently used drugs:
  • Lyrica (100 Mg, Unk)
  • Promocard (30 Mg, Daily)
  • Lyrica (150 Mg, Unk)
Soon after that, the consumer experienced the following side effects:
  • Prinzmetal Angina
This opens a possibility that Ascal treatment could cause the above reactions, including prinzmetal angina, and some male subjects may be more susceptible.

Pleural Calcification, Alveolitis, Pulmonary Fibrosis, Influenza Virus Test Positive
A 69-year-old male patient (weight: NA) from with the following symptoms/conditions: NA started Ascal treatment (dosage: NA) on Jan 01, 2008. Soon after starting Ascal treatment, the subject experienced various side effects, including:
  • Pleural Calcification
  • Alveolitis
  • Pulmonary Fibrosis
  • Influenza Virus Test Positive
Concurrently used drugs:
  • Tramadol Hcl
  • Metformin (Bid)
  • Plavix
  • Insulin
  • Lyrica (300mg - Daily)
  • Pantozol
  • Movicolon
  • Oxicontin
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Ascal.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Ascal Side Effects

    Did You Have a Ascal Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Ascal for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Ascal Safety Alerts, Active Ingredients, Usage Information

    More About Ascal

    Side Effects reported to FDA: 30

    Ascal safety alerts: No

    Reported deaths: 5

    Reported hospitalizations: 13

    Latest Ascal clinical trials